Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Ligand Pharmaceuticals Inc
F:LGDN
Ligand Pharmaceuticals Inc
F:LGDN
Price:
264
EUR
-2.94%
Market Cap:
€4.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Ligand Pharmaceuticals Inc
F:LGDN
|
US |
|
U
|
Upbound Group Inc
F:RAC
|
US |
|
C
|
Corticeira Amorim SGPS SA
XMUN:AS4
|
PT |
Wall St Price Targets
LGDN Price Forecast
Based on 12 analysts
Based on 12 analysts
-27% Downside
from
€264
today
Ligand Pharmaceuticals Inc (LGDN)’s 12-month stock price forecast through September 2027 has a consensus target of €192.98, implying 27% downside. The forecast is based on price targets from 12 Wall Street analysts.
LGDN Analyst Rating
No ratings yet
No ratings yet
Ligand Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LGDN's stock price target?
Price Target
192.98
EUR
192.98
EUR
According to Wall Street analysts, the average 1-year price target for LGDN is 192.98 EUR with a low forecast of 136.81 EUR and a high forecast of 224.56 EUR.
What is the Revenue forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 8 years is 19%.
What is the Gross Profit forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
21%
21%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 7 years is 21%.
What is the Pre-Tax Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
31%
31%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 31%.
What is the Net Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
26%
26%
The compound annual growth rate for Net Income over the next 7 years is 26%.